PPAR-γ receptor ligands: novel therapy for pituitary adenomas
Anthony P. Heaney(Cedars-Sinai Medical Center), Шломо Мелмед(Cedars-Sinai Medical Center)
Cited by 164
Related Papers
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
|Journal of Clinical Investigation|2011|256
ErbB Receptor-Driven Prolactinomas Respond to Targeted Lapatinib Treatment in Female Transgenic Mice
|Endocrinology|2014|37
Clusterin and FOXL2 Act Concordantly to Regulate Pituitary Gonadotroph Adenoma Growth
|Molecular Endocrinology|2012|30
Targeting the ERK pathway for the treatment of Cushing's disease
|Oncotarget|2016|25